Skip directly to content


Funding innovative medical research by European investigators since 2014

The BMS/Pfizer European Thrombosis Investigator-Initiated Research Program (ERISTA) was established to fund innovative medical research by European investigators.


Our mission

To improve the clinical care of patients treated with novel oral anticoagulants (NOACs), in particular apixaban, in disease areas relevant to current licensed indications or other areas that are of special interest due to unmet medical needs.


More info

This site is intended for the use of investigators considering a submission or intending to submit to the ERISTA program. It is NOT intended to provide product information.